Research paper
View All-
Gao Shouda
A comparative analysis of Denosumab and Zoledronic acid effects on bone metabolism and bone mineral density in individuals with osteoporotic vertebral compression fractures
-
Klisic Aleksandra
Serum galectin-3 and fibroblast growth factor-23 levels in relation with type 2 diabetes and cardiovascular risk
-
Shaoqiang Wu
The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease
-
Bingxun Wang
Effects of colchicine adjuvant therapy on disease control, serum NALP3, sICAM-1, MMP-9 and MMP-13 in patients with coronary heart disease and acute gout attack
-
Lai Xijie
Serum TNF-a and biomarkers levels after tenofovir therapy in patients with serum HBeAg-positive chronic hepatitis B
-
Chen Wang
Predictive value of systemic immune inflammation index combined with coagulation index in traumatic coagulopathy in patients with severe trauma
-
Kong Lingyan
Clinical and biochemical efficacy zoledronic acid and denosumab combination: focus serum inflammatory factor level (serum ifcs), bone gla protein (bgp), and bone turnover markers b-collagen degradation product (b-ctx), and procollagen type 1 n-terminal pr
-
Liu JunFei
Complement pathway: Risk molecular pattern of cardiovascular diseases in patients with diabetic nephropathy
-
Wang Baoyue
The diagnostic value plasma procalcitonin (PCT) and serum amyloid A protein (SAA) in children with mycoplasma pneumonia